Aranesp® Therapy Study
for cardiovascular events in patients with Chronic Kidney Disease (CKD)

Challenge

  • Motivate and inform patients and their carers participating in a global cardiovascular study involving up to 4 years study participation.

Solutions

  • A patient information and award program (customized by country) focused on study participation and completion of key milestone visits over the course of the study.

Result

  • Unique patient retention program supporting study patients in 14 countries including the US, Europe and Australia.

Project Scope: Patient Retention, carer support

Back to list image retention, cardiovascular, global, metabolic, ckd, kidney disease    

Other Portfolio Pieces: